Carbogen Amcis

Carbogen Amcis is an established, global CDMO with over 40 years of collective experience, offering integrated services from early-stage drug substance development through to commercial-scale manufacturing of APIs and sterile injectables. The company operates eight sites across Switzerland, the UK, France, the Netherlands, and China, providing scalable capacity from grams to multi-thousand-kilogram scales. Recent strategic moves, including a credit facility refinancing, a co-investment for capacity expansion, and an alliance for ADC manufacturing, position it for continued growth in the outsourced pharmaceutical services market.

Integrated CDMO services for Drug Substance (API development & manufacturing, including HPAPIs) and Sterile Drug Product (injectables). Specialized capabilities in cholesterol, vitamin D analogs, and a strategic alliance for integrated ADC manufacturing.

Operates in the highly competitive global CDMO market, competing with large players like Lonza, Catalent, and Thermo Fisher Scientific, as well as numerous specialized mid-sized and regional CDMOs. Its differentiation lies in its integrated API-to-sterile-product services, Swiss quality reputation, and niche in HPAPIs and now ADCs.